Clinical and biological characteristics of acute myeloid leukemia with 20–29% blasts: a retrospective single-center study-Reference-Cited by-同舟云学术

Clinical and biological characteristics of acute myeloid leukemia with 20–29% blasts: a retrospective single-center study

Published:2018-10-10 Issue:5 Volume:60 Page:1136-1145
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Mei Chen¹²³,Ren Yanling¹²³,Zhou Xinping¹²³,Ye Li¹²³,Ma Liya¹²³,Luo Yingwan¹²³,Lin Peipei¹²³,Xu Weilai¹³,Lu Chenxi¹²³,Yang Haiyang¹²³,Yu Wenjuan¹³,Mao Liping¹³,Wei Juying¹³,Jin Jie¹³,Tong Hongyan¹²³

Affiliation:

1. Department of Hematology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China;

2. Myelodysplastic Syndromes Diagnosis and Therapy Center, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China;

3. Institute of Hematology, Zhejiang University, Hangzhou, China

Funder

National Natural Science Foundation of China Grants

Major Program Fund of the Science Technology Department of Zhejiang Province

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2018.1515938

Reference33 articles.

1. Proposals for the classification of the myelodysplastic syndromes

2. The World Health Organization (WHO) classification of the myeloid neoplasms

3. Acute myeloid leukemia-type chemotherapy for newly diagnosed patients without antecedent cytopenias having myelodysplastic syndrome as defined by French-American-British criteria: a Cancer and Leukemia Group B Study.

4. Effect of Diagnosis (Refractory Anemia With Excess Blasts, Refractory Anemia With Excess Blasts in Transformation, or Acute Myeloid Leukemia [AML]) on Outcome of AML-Type Chemotherapy

5. Outcome of older patients with acute myeloid leukemia

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of CXCR1, CXCR2, CXCR3, CXCR5, and CXCR6 Ligands in Molecular Cancer Processes and Clinical Aspects of Acute Myeloid Leukemia (AML);Cancers;2023-09-14

2. A Phenogenetic Axis that Modulates Clinical Manifestation and Predicts Treatment Outcome in Primary Myeloid Neoplasms;Cancer Research Communications;2022-04-26